Animal propagation and genomic survey of a genotype 1 isolate of Cryptosporidium parvum

Molecular and Biochemical Parasitology

Volumn 108, Issue 2, 2000, Pages 187-197

  Widmer, G ^a   Akiyoshi, D ^a   Buckholt, M A ^a   Feng, X ^a   Rich, S M ^a   Deary, K M ^a   Bowman, C A ^a   Xu, P ^b   Wang, Y ^b   Wang, X ^b   Buck, G A ^b   Tzipori, S ^a  

^a TUFTS UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cryptosporidium parvum; Genome sequence survey; Genotype; Gnotobiotic pig; Restriction fragment length polymorphism

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; GENE SEQUENCE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SWINE;

ANIMALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; GENOME, PROTOZOAN; GENOTYPE; GERM-FREE LIFE; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; SWINE;

ANIMALIA; BACTERIA (MICROORGANISMS); CRYPTOSPORIDIUM PARVUM; HUMAN IMMUNODEFICIENCY VIRUS; PRIMATES; PROTOZOA; SUS SCROFA;

EID: 19244380275     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(00)00211-5     Document Type: Article

References (31)

1. Tzipori S. Cryptosporidiosis in perspective. Adv. Parasitol. 27:1988;63-130.
2. Guerrant R.L. Cryptosporidiosis: An emerging, highly infectious threat. Emerg. Infect. Dis. 3:1997;51-58.
3. Widmer G., Tzipori S., Fichtenbaum C.J., Griffiths J.K. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J. Infect. Dis. 178:1998;834-840.
4. Peng M.M., Xiao L., Freeman A.R., Arrowood M.J., Escalante A.A., Weltman A.C. et al. Genetic polymorphisms among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg. Infect. Dis. 3:1997;567-573.
5. Patel S, Pedraza-Diaz S, McLauclin J, Casemore DP. Molecular characterization of Cryptosporidium parvum from two large suspected waterborne outbreaks, Commun Dis Public Health 1998;231-233.
6. Sulaiman I.M., Xiao L., Yang C., Escalante L., Moore A., Beard C. et al. Differentiating human from animal isolates of Cryptosporidium parvum. Emerg. Infect. Dis. 4:1998;681-685.
7. McLauchlin J., Pedraza-Diaz S., Amar-Hoetzeneder C., Nichols G.L. Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis. J. Clin. Microbiol. 37:1999;3153-3158.
8. Okhuysen P.C., Chappell C.L., Crabb J.H., Sterling C.R., DuPont H.L. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 180:1999;1275-1281.
9. Spano F., Putignani L., Crisanti A. et al. A multilocus genotypic analysis of Cryptosporidium parvum from different hosts and geographical origins. J. Clin. Microbiol. 36:1998;3255-3259.
10. Widmer G., Tchack L., Chappell C.L., Tzipori S. Sequence polymorphism in the β-tubulin gene reveals heterogeneous and variable population structure in Cryptosporidium parvum. Appl. Environ. Microbiol. 64:1998;4477-4481.
11. Tzipori S., Rand W., Griffiths J., Widmer G., Crabb J.H. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin. Diagn. Lab. Immunol. 1:1994;450-463.
12. Theodos C., Sullivan K., Griffiths J., Tzipori S. The profile of healing and non-healing Cryptosporidium parvum infection in mice with functional B and T lymphocytes: The extent of IFNg modulation determines infection outcome. Infect. Immun. 65:1997;4761-4769.
13. Griffiths J., Theodos C., Paris M., Tzipori S. The interferon-γ gene-disrupted mouse: a highly susceptible model for evaluation of therapeutic agents against Cryptosporidium parvum. J. Clin. Microbiol. 36:1998;2503-2508.
14. Spano F., Putignani L., McLaughlin J., Casemore D.P., Crisanti A. PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin. FEMS Microbiol. Lett. 152:1997;209-217.
15. Spano F., Putignani L., Guida S., Crisanti A. Cryptosporidium parvum: PCR-RFLP analysis of the TRAP-C1 (thrombospondin-related adhesive protein of Cryptosporidium-1) gene discriminates between two alleles differentially associated with parasite isolates of animal and human origin. Exp. Parasitol. 90:1998;195-198.
16. Blunt D.S., Khramtsov N.V., Upton S.J., Montelone B.A. Molecular karyotype analysis of Cryptosporidium parvum: evidence for eight chromosomes and a low-molecular-size molecule. Clin. Diagn. Lab. Immunol. 4:1997;11-13.
17. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning, A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, New York.
18. Roe B.A., Crabtree J.S., Khan A.S. DNA Isolation and Sequencing. 1996;Wiley, New York.
19. Leng X., Mosier D.A., Oberst R.D. Differentiation of Cryptosporidium parvum, C. muris and C. baileyi by PCR-RFLP analysis of the 18S rRNA gene. Vet. Parasitol. 62:1996;1-7.
20. Morgan U.M., Xiao L., Fayer R., Graczyk T.K., Lal A.A., Deplazes P. et al. Phylogenetic analysis of Cryptosporidium isolated from captive reptiles using 18S rDNA sequence data and RAPD analysis. J. Parasitol. 85:1999;525-530.
21. Xiao L., Escalante L., Yang C., Sulaiman I., Escalante A.A., Montali R.J. et al. Phylogenetic analysis of Cryptosporidium parasites based on the small-subunit rRNA gene locus. Appl. Environ. Microbiol. 65:1999;1578-1583.
22. Carraway M., Tzipori S., Widmer G. New RFLP marker in Cryptosporidium parvum identifies mixed parasite populations and genotypic instability in response to host change. Infect. Immun. 65:1997;3958-3960.
23. Yang S., Healey M.C., Du C. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice. FEMS Immunol. Med. Microbiol. 13:1996;141-145.
24. Liu C., Vigdorovich V., Kapur V., Abrahamsen M.S. A random survey of the Cryptosporidium parvum genome. Infect. Immun. 67:1999;3960-3969.
25. Ellis J., Griffin H., Morrison D., Johnson A.M. Analysis of dinucleotide frequency and codon usage in the phylum Apicomplexa. Gene. 126:1993;163-170.
26. Mewes H.W., Albermann K., Bahr M., Frishman D., Gleissner A., Hani J. et al. Overview of the yeast genome [published erratum appears in Nature 1997, June 12;387(6634):737]. Nature. 387:1997;7-65.
27. Riley M. Functions of the gene products of Escherichia coli. Microbiol. Rev. 57:1993;862-952.
28. Tzipori S., Gunzer F., de Montigny L., Donnenberg M., Kaper J., Donohue-Rolfe A. The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect. Immun. 63:1995;3621-3627.
29. Kondova I., Mansfield K., Buckholt M., Stein B., Lackner A., Tzipori S. Transmission of Enterocytozoon bieneusi of human and primate origin in immunosuppressed gnotobiotic piglets. Infect. Immun. 66:1998;5515-5519.
30. Theodos C.M., Griffiths J.K., D'Onfro J., Fairfield A., Tzipori S. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and animal models. Antimicrob. Agents Chemother. 42:1998;1959-1965.
31. Vasquez J.R., Gooze L., Kim K., Gut J., Peterson C., Nelson R.G. Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidilate synthase gene from human and bovine isolates of Cryptosporidium parvum. Mol. Biochem. Parasitol. 79:1996;153-156.